At-home heart failure treatment shows promise in University of Florida study

The Gator SCALES-WHF study evaluated 21 patients deemed at imminent risk for hospital admission due to fluid buildup, a condition typically requiring a week of inpatient care. Researchers found that patients could safely self-administer the medication, which delivers 80 mg of furosemide over five hours, avoiding the intense diuretic spikes associated with rapid injections. Participants successfully completed 95 doses during the trial, reporting minimal device or safety complications.

Principal Investigator Dr. Mustafa M. Ahmed noted that the pathway offers a critical alternative for patients who no longer respond to oral diuretics. By moving the treatment to the home environment, providers can bypass emergency department overcrowding while reducing the burden on patients. With 30-day readmission rates for treatment failure remaining rare, the findings suggest that structured outpatient care using the Lasix ONYU system may soon become a standard practice for chronic heart failure management.